GRAPPA 2024
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 Annual Meeting
Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 Annual Meeting
Dafna D. Gladman, Wilson Bautista-Molano, Denis Poddubnyy, William Tillett and Alice B. Gottlieb
J Rheumatol December 1 2025, 52 (Suppl 3) 1-3
HTML | PDF
Young-GRAPPA 2024: Progress, Achievements, and Strategic Developments
Andre L. Ribeiro, Gizem Ayan, Hanna J. Johnsson, Roxana Coras, Michelle Mulder, Daniela B. Tovar-Bastidas, Dimitri L.F. Silva, Arani Vivekanantham and Fabian Proft
J Rheumatol December 1 2025, 52 (Suppl 3) 4-7
HTML | PDF
Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual Meeting
Sarah Romanelli, Beth Childs, Vibeke Strand, April W. Armstrong, Lourdes M. Perez-Chada, Joseph F. Merola and Alice B. Gottlieb
J Rheumatol December 1 2025, 52 (Suppl 3) 8-11
HTML | PDF
Discovery and Clinical Validation of C1M and C4M as Soluble Biomarkers for Diagnosis, Prognosis, and Symptom Prediction in Psoriatic Disease and Other Inflammatory Arthropathies
Maria-Angeliki Gkini, Wilson Liao, Kurt de Vlam, Vinod Chandran and Signe Holm Nielsen
J Rheumatol December 1 2025, 52 (Suppl 3) 12-15
HTML | PDF
Toward Increasing Precision in the Early Diagnosis of Psoriatic Arthritis
Andre L. Ribeiro, Lihi Eder, Sibel Z. Aydin and Gurjit S. Kaeley
J Rheumatol December 1 2025, 52 (Suppl 3) 16-18
HTML | PDF
Diagnosis and Assessment of Psoriasis for the Rheumatologist: A Workshop From the GRAPPA 2024 Annual Meeting
Maria-Angeliki Gkini, Lyn Chinchay, Chris A. Lindsay, Manuel Franco, Juan Raul Castro Ayarza and Kristina Callis Duffin
J Rheumatol December 1 2025, 52 (Suppl 3) 19-22
HTML | PDF
Advancing Psoriatic Disease Knowledge: Highlights From the GRAPPA 2024 Trainee Symposium
Clementina López-Medina, Michelle Mulder, Lihi Eder and M. Elaine Husni
J Rheumatol December 1 2025, 52 (Suppl 3) 23-29
HTML | PDF
Challenges and Opportunities in Psoriatic Disease: An Integrated View of the Future
Lyn Chinchay, Kaiyang Song, Jeffrey Stark, Nicole L. Ward and Iain B. McInnes
J Rheumatol December 1 2025, 52 (Suppl 3) 30-34
HTML | PDF
GRAPPA Debate: Be it Resolved That Clinical Enthesitis Indices Do Not Reflect True Enthesitis and Hence Should Be Discontinued
Betul Macit, Sibel Z. Aydin and Atul Deodhar
J Rheumatol December 1 2025, 52 (Suppl 3) 35-39
HTML | PDF
Update on the Axial Involvement in Psoriatic Arthritis (AXIS) Project
Murat Torgutalp, Denis Poddubnyy and Dafna D. Gladman
J Rheumatol December 1 2025, 52 (Suppl 3) 40-41
HTML | PDF
World Café Report From the GRAPPA 2024 Annual Meeting and Trainee Symposium: Exploring GRAPPA’s Future Priorities
Shikha Singla, Stephen R. Pennington, Sam T. Hwang and Jessica A. Walsh
J Rheumatol December 1 2025, 52 (Suppl 3) 42-48
HTML | PDF
How to Manage Cardiovascular Disease in Psoriatic Disease: Evidence and Time Management in Clinic
Maria-Angeliki Gkini, Pamela Díaz, Cheryl F. Rosen and Claudia Goldenstein-Schainberg
J Rheumatol December 1 2025, 52 (Suppl 3) 49-51
HTML | PDF
What Clinicians Need to Know About Glucagon-like Peptide 1 Agonists
Dimitri Luz Felipe da Silva, Shikha Singla and Philip J. Mease
J Rheumatol December 1 2025, 52 (Suppl 3) 52-54
HTML | PDF
MHC-I-opathy: A Unified Concept for the Etiology of Several Major Histocompatibility Complex–Associated Conditions Including Psoriasis and Psoriatic Arthritis Andrea Leung, Kerem Abacar, Georgia Marquez-Grap, Allison Kranyak, Wilson Liao and Dennis McGonagle
J Rheumatol December 1 2025, 52 (Suppl 3) 55-58
HTML | PDF
GRAPPA 2024: Key Project Advances
Gizem Ayan, Philip S. Helliwell, Christine A. Lindsay, Philip J. Mease, Denis O’Sullivan, Stephen R. Pennington, Fabian Proft and Oliver FitzGerald
J Rheumatol December 1 2025, 52 (Suppl 3) 59-62
HTML | PDF
Managing Musculoskeletal Symptoms in Patients With Psoriasis: Who Should Be in the Driver’s Seat?
Karen Briner, Pamela Díaz, Fabian Proft and Laura J. Savage
J Rheumatol December 1 2025, 52 (Suppl 3) 63-65
HTML | PDF
How to Identify and Monitor Axial and Peripheral Psoriatic Arthritis by Magnetic Resonance Imaging
Pamela Díaz, Walter P. Maksymowych and Mikkel Østergaard
J Rheumatol December 1 2025, 52 (Suppl 3) 66-71
HTML | PDF
GRAPPA 2024: Innovations in Education Workshop
Gizem Ayan, M. Elaine Husni, Ashish J. Mathew, Iain B. McInnes and Philip J. Mease
J Rheumatol December 1 2025, 52 (Suppl 3) 72-74
HTML | PDF
The Scientific Method and Advancing Omic Technologies: Breakthroughs in Psoriatic Disease
Hanna J. Johnsson, Stephen R. Pennington and Nicole L. Ward
J Rheumatol December 1 2025, 52 (Suppl 3) 75-79
HTML | PDF
Hot Topics: Exploring Artificial Intelligence and Inflammatory Memory in the Management of Psoriatic Diseases
Huidi Shucheng, April W. Armstrong, Liv Eidsmo and Denis Poddubnyy
J Rheumatol December 1 2025, 52 (Suppl 3) 80-82
HTML | PDF
A New Mouse Model of Psoriatic Arthritis
Bahram Razani, Vinod Chandran, Kurt de Vlam, Wilson Liao, Barbara A. Malynn and Averil Ma
J Rheumatol December 1 2025, 52 (Suppl 3) 83-86
HTML | PDF
Composite Outcome Measures for Psoriatic Arthritis: Project Updates 2024
Andre L. Ribeiro, Tommy Kok Annfeldt, Dafna D. Gladman, William Tillett, Ana-Maria Orbai and Ying Ying Leung
J Rheumatol December 1 2025, 52 (Suppl 3) 87-90
HTML | PDF
GRAPPA 2024 Annual Meeting: An Update on Major Project Milestones
Keith Colaco, Lihi Eder, Suzanne M. Grieb, Ying Ying Leung, Ennio Lubrano, Philip J. Mease, Lourdes M. Perez-Chada, Denis Poddubnyy, Enrique R. Soriano and Vinod Chandran
J Rheumatol December 1 2025, 52 (Suppl 3) 91-93
HTML | PDF
GRAPPA Patient Research Partner Network Composition and Engagement: A Survey to Determine Strategic Areas for Growth
Christine A. Lindsay, Suzanne M. Grieb and Arnon Katz
J Rheumatol December 1 2025, 52 (Suppl 3) 94-97
HTML | PDF
GRAPPA 2024 Meeting: Advances in Psoriatic Disease Research From Pilot Grant Awardees
Keith Colaco, Omar Alzayat, Steven Dang, Caroline Gross, Philip S. Helliwell, Paras Karmacharya, David Simon, Axel Svedbom, Vinod Chandran, Wilson Liao and Kurt de Vlam
J Rheumatol December 1 2025, 52 (Suppl 3) 98-105
HTML | PDF